Literature DB >> 27249556

Left ventricular mechanical dispersion is associated with nonsustained ventricular tachycardia in hypertrophic cardiomyopathy.

Mikko Jalanko1, Mika Tarkiainen2, Petri Sipola2, Pertti Jääskeläinen3, Kirsi Lauerma4, Mika Laine1, Markku S Nieminen1, Markku Laakso5, Tiina Heliö1, Johanna Kuusisto5.   

Abstract

OBJECTIVE: We assessed the value of speckle tracking two-dimensional (2D) strain echocardiography (2DSE) measured mechanical dispersion (MD) with other imaging and electrocardiographic parameters in differentiating hypertrophic cardiomyopathy (HCM) patients with and without nonsustained ventricular tachycardia (NSVT) on 24-h ambulatory ECG monitoring. METHODS AND
RESULTS: We studied 31 patients with HCM caused by the Finnish founder mutation MYBPC3-Q1061X and 20 control subjects with comprehensive 2DSE echocardiography and cardiac magnetic resonance imaging (CMRI). The presence of NSVT was assessed from ambulatory 24-h ECG monitoring. NSVT episodes were recorded in 11 (35%) patients with HCM. MD was significantly higher in HCM patients with NSVT (93 ± 41 ms) compared to HCM patients without NSVT (50 ± 18 ms, p = 0.012) and control subjects (41 ± 16 ms, p < 0.001). MD was the only variable independently associated with the presence of NSVT (OR: 1.60, 95% CI: 1.05-2.45, p = 0.030). Assessed by ROC curves, MD performed best in differentiating between HCM patients with and without NSVT (AUC = 0.81).
CONCLUSIONS: Increased mechanical dispersion was associated with NSVT in HCM patients on 24-h ambulatory ECG monitoring. Key messages The prediction of sudden cardiac death in hypertrophic cardiomyopathy remains a challenge and novel imaging methods are required to identify individuals at risk of malignant ventricular arrhythmias. Mechanical dispersion by speckle tracking echocardiography is associated with NSVT on 24-h ambulatory ECG monitoring in patients with hypertrophic cardiomyopathy.

Entities:  

Keywords:  Arrhythmia; cardiac magnetic resonance; echocardiography; risk assessment; speckle tracking; sudden cardiac death

Mesh:

Substances:

Year:  2016        PMID: 27249556     DOI: 10.1080/07853890.2016.1186826

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  6 in total

Review 1.  Multimodality imaging predictors of sudden cardiac death.

Authors:  Fancesco Bandera; Lilit Baghdasaryan; Giulia Elena Mandoli; Matteo Cameli
Journal:  Heart Fail Rev       Date:  2020-05       Impact factor: 4.214

2.  CMR derived left ventricular septal convexity in carriers of the hypertrophic cardiomyopathy-causing MYBPC3-Q1061X mutation.

Authors:  Mika Tarkiainen; Petri Sipola; Mikko Jalanko; Tiina Heliö; Pertti Jääskeläinen; Kati Kivelä; Mika Laine; Kirsi Lauerma; Johanna Kuusisto
Journal:  Sci Rep       Date:  2019-04-11       Impact factor: 4.379

3.  Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy.

Authors:  Pertti Jääskeläinen; Jagadish Vangipurapu; Joose Raivo; Teemu Kuulasmaa; Tiina Heliö; Katriina Aalto-Setälä; Maija Kaartinen; Erkki Ilveskoski; Sari Vanninen; Liisa Hämäläinen; John Melin; Jorma Kokkonen; Markku S Nieminen; Markku Laakso; Johanna Kuusisto
Journal:  ESC Heart Fail       Date:  2019-02-18

4.  Value of peak strain dispersion in discovering left ventricular dysfunction in diabetes mellitus.

Authors:  Chunmei Li; Miao Yuan; Kun Li; Wenjuan Bai; Li Rao
Journal:  Sci Rep       Date:  2020-12-08       Impact factor: 4.379

5.  Left ventricular characteristics of noncompaction phenotype patients with good ejection fraction measured with cardiac magnetic resonance.

Authors:  Anna Reka Kiss; Zsófia Gregor; Adam Furak; Attila Tóth; Márton Horváth; Liliana Szabo; Csilla Czimbalmos; Zsofia Dohy; Bela Merkely; Hajnalka Vago; Andrea Szucs
Journal:  Anatol J Cardiol       Date:  2021-08       Impact factor: 1.596

6.  Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy.

Authors:  Limin Liu; Shangyu Liu; Lishui Shen; Bin Tu; Zhicheng Hu; Feng Hu; Lihui Zheng; Ligang Ding; Xiaohan Fan; Yan Yao
Journal:  Clin Cardiol       Date:  2020-08-18       Impact factor: 2.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.